FDA NDC Directory · JSON-LD · Markdown

REDEMPLO

NDC 84141-025 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameplozasiran
Labeler / ManufacturerArrowhead Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA219947
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsPLOZASIRAN (25 mg/.5mL)
Marketing started20251119
Package count1

External sources

Source: openFDA. Public-domain (CC0).